000424

1995, September, 95-97. 170. Olsson, S. The Role of the WHO Programme on international drug monitoring in coordinating worldwide drug safety efforts / S.Olsson // Drug Safety, 1998/ - 19: 1-10. 171. Pharmacokinetic evaluation of linezolid in patients with major thermal injuries / R. Le Floch [et al.] // PatholBiol. - 2010. - Apr; 58(2): p. 27­ 31. 172. Pirmohamed, M. Adverse drug reactions / M. Pirmohamed, A.M. Breckenridge, N.R. Kitteringham, B.K Park // BMJ, 1998; 316:1295-1298 (25 April). 173. Pirmohamed, M. Adverse drug reactions / M. Pirmohamed, A.M. Breckenridge, N.R. Kitteringham, B.K. Park // BMJ, 1998; 316:1295-1298 (25 April). 174. Rodriguez-Monguio R. Assessing the economic impact of adverse drug effects / R. Rodriguez-Monguio, M. Otero, J. Rovira // Pharmacoeconomics. - 2003; 21(9): 623-50. 175. Rupp, M.T. Value of Community Pharmacists’ Interventions to Correct Prescribing Errors / M.T Rupp. - Annals of Pharmacotherapy, 1992; 26: 1580-1584. 176. Sarpal, N. Drag administration - Infusion Devices’, in Dougherty L. and Lister S (editors). - 2008. - The Royal Marsden Hospital Manual of clinical nursing procedures (7th edition), Oxford: Blackwell Publishing. (III). 177. Schoenemann, J. Unerwunschte Arzneimittelwirkungen in der klinik / J. Schoenemann, K.H. Munter, S. Enayati Kashani // Dtsch. Med. Wochenschr., 1998, 123 (15), 448-452. 178. Schousboe, L.P. O Correct documentation of drug prescriptions / L.P. Schousboe, O. Tandrup // Ugeskr. Laeger, 1999, 2, 161(31), 4389-4392. 179. Seeger, J.D. Characteristics associated with ability to prevent adverse drug reactions in hospitalized patients / J.D. Seeger, S.X. Kong, G.T. 196